Other: Quality of life assessment ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 122 | Superficial siderosis | 1 |
122. Superficial siderosis
Clinical trials : 4 / Drugs : 9 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04200664 (ClinicalTrials.gov) | February 7, 2020 | 10/12/2019 | Audiovestibular Function in Infratentorial Superficial Siderosis | Clinical and Imaging Biomarkers of Audiovestibular Function in Infratentorial Superficial Siderosis | Siderosis;Neurological Disorder;Rare Diseases;Age Related Hearing Loss;Presbycusis | Diagnostic Test: Hearing assessment;Diagnostic Test: Vestibular/balance assessment;Other: Quality of life assessment;Diagnostic Test: Olfactory (smell) function testing;Genetic: DNA bio-banking | University College, London | NIHR UCLH BRC;The Bernice Bibby Research Trust | Completed | 18 Years | N/A | All | 90 | United Kingdom |